1. R. S. Dreifus, Z. Filip, D. M. Sexton, and Y. Watanabe. Electrophysiological and clinical effects of a new antiarrhythmic agent: Disopyramide.Am. J. Cardiol. 31:129 (1973).
2. P. P. Mathur. Cardiovascular effects of a new antiarrhythmic agent, SC-7031.Curr. Ther. Res. 5:343–350 (1963).
3. A. Sekyia and E. M. Vaughan Williams. A comparison of the antifibrillatory actions and effects on intravellular cardiac potentials of pronethalol, disopyramide and quinidine.Br. J. Pharmacol. 21:473–481 (1963).
4. B. K. Yeh, P. K. Sung, and B. J. Scherlag. Effects of disopyramide on electrophysiological and mechanical properties of the heart.J. Pharm. Sci. 62:1924–1929 ((1973).
5. B. Befeler, A. Castellanos, Jr., D. E. Wells, M. C. Vaguiero, B. K. Yeh, and R. J. Myerburg. Electrophysiological effects of disopyramide phosphate: A new antiarrhythmic agent.Am. J. Cardiol. 31:119 (1973).